Cargando…

Selenium-based compounds: Emerging players in the ever-unfolding story of SOD1 in amyotrophic lateral sclerosis.

Detalles Bibliográficos
Autores principales:	Yerbury, Justin J., Cashman, Neil R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479490/ https://www.ncbi.nlm.nih.gov/pubmed/32891934 http://dx.doi.org/10.1016/j.ebiom.2020.102997

Ejemplares similares

Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis
por: McAlary, Luke, et al.
Publicado: (2019)

Corrigendum: Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis
por: McAlary, Luke, et al.
Publicado: (2020)

Novel Selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis
por: Amporndanai, Kangsa, et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises
por: McAlary, Luke, et al.
Publicado: (2020)

The relevance of contact-independent cell-to-cell transfer of TDP-43 and SOD1 in amyotrophic lateral sclerosis
por: Hanspal, Maya A., et al.
Publicado: (2017)

A copper chaperone–mimetic polytherapy for SOD1-associated amyotrophic lateral sclerosis
por: McAlary, L., et al.
Publicado: (2022)

Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis
por: Paré, Bastien, et al.
Publicado: (2018)

Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells
por: Pokrishevsky, Edward, et al.
Publicado: (2017)

Aberrant Localization of FUS and TDP43 Is Associated with Misfolding of SOD1 in Amyotrophic Lateral Sclerosis
por: Pokrishevsky, Edward, et al.
Publicado: (2012)

Misfolding at the synapse: A role in amyotrophic lateral sclerosis pathogenesis?
por: Lum, Jeremy S., et al.
Publicado: (2022)

SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization
por: Banci, Lucia, et al.
Publicado: (2008)

Metal-deficient SOD1 in amyotrophic lateral sclerosis
por: Hilton, James B., et al.
Publicado: (2015)

P2X7 receptor antagonism in amyotrophic lateral sclerosis
por: Sluyter, Ronald, et al.
Publicado: (2017)

Is SOD1 loss of function involved in amyotrophic lateral sclerosis?
por: Saccon, Rachele A., et al.
Publicado: (2013)

Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells
por: Pokrishevsky, Edward, et al.
Publicado: (2018)

Enteroviral Infection: The Forgotten Link to Amyotrophic Lateral Sclerosis?
por: Xue, Yuan Chao, et al.
Publicado: (2018)

Lupus nephritis in Bangladesh: unfolding the story
por: Mubarak, Muhammed
Publicado: (2016)

Structural and Functional Analysis of Human SOD1 in Amyotrophic Lateral Sclerosis
por: Moreira, Lorenna Giannini Alves, et al.
Publicado: (2013)

SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis
por: Tafuri, Francesco, et al.
Publicado: (2015)

SOD1 in Amyotrophic Lateral Sclerosis: “Ambivalent” Behavior Connected to the Disease
por: Pansarasa, Orietta, et al.
Publicado: (2018)

P2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1(G93A) amyotrophic lateral sclerosis mice
por: Bartlett, Rachael, et al.
Publicado: (2017)

Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis?
por: Chisholm, Christen G., et al.
Publicado: (2022)

Glutathionylation potentiates benign superoxide dismutase 1 variants to the toxic forms associated with amyotrophic lateral sclerosis
por: McAlary, Luke, et al.
Publicado: (2013)

FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
por: Kabashi, Edor, et al.
Publicado: (2011)

Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis
por: Vehviläinen, Piia, et al.
Publicado: (2014)

Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
por: Jeon, Gye Sun, et al.
Publicado: (2018)

SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity
por: Berdyński, Mariusz, et al.
Publicado: (2022)

Untangling the knot: Lifetime physical exercise and amyotrophic lateral sclerosis
por: Chiò, Adriano, et al.
Publicado: (2021)

The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!
por: Tagoe, Daniel N. A., et al.
Publicado: (2015)

Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
por: Nizzardo, M., et al.
Publicado: (2016)

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice
por: Juranek, Judyta K., et al.
Publicado: (2016)

Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations
por: Tokuda, Eiichi, et al.
Publicado: (2016)

Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes
por: Canosa, Antonio, et al.
Publicado: (2022)

P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons
por: Bartlett, Rachael, et al.
Publicado: (2022)

Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis
por: Iyer, Abhirami K., et al.
Publicado: (2018)

The Environment and Amyotrophic Lateral Sclerosis: Converging Clues from Epidemiologic Studies Worldwide
por: Vinceti, Marco
Publicado: (2012)

Astrocyte-based cell therapy: new hope for amyotrophic lateral sclerosis patients?
por: Barbeito, Luis
Publicado: (2018)

A Commentary on TDP-43 and DNA Damage Response in Amyotrophic Lateral Sclerosis
por: Mitra, Joy, et al.
Publicado: (2019)

The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial
por: Dalla Bella, Eleonora, et al.
Publicado: (2021)

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
por: Banerjee, Rebecca, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1p4k1klhm96tkdqqmfvch1sse4